These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 37884692)
21. Comparative effectiveness of sleeve gastrectomy vs Roux-en-Y gastric bypass in patients giving birth after bariatric surgery: reinterventions and obstetric outcomes. Chao GF; Yang J; Peahl AF; Thumma JR; Dimick JB; Arterburn DE; Telem DA Surg Endosc; 2022 Sep; 36(9):6954-6968. PubMed ID: 35099628 [TBL] [Abstract][Full Text] [Related]
22. Bariatric surgery during the evolution of fatty liver-A randomized clinical trial comparing gastric bypass and sleeve gastrectomy based on transient elastography. de Barros F; Fonseca ABM Clin Obes; 2020 Dec; 10(6):e12393. PubMed ID: 32885600 [TBL] [Abstract][Full Text] [Related]
23. The incidence of iron deficiency anemia post-Roux-en-Y gastric bypass and sleeve gastrectomy: a systematic review. Enani G; Bilgic E; Lebedeva E; Delisle M; Vergis A; Hardy K Surg Endosc; 2020 Jul; 34(7):3002-3010. PubMed ID: 31485928 [TBL] [Abstract][Full Text] [Related]
24. BYPASS VS. SLEEVE AND ITS EFFECTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: WHAT IS THE BEST TECHNIQUE? Goldoni MB; Fontes PRO; GuimarÃes MM; Diedrich-Neto JA; Nogueira T; Teixeira UF; Giacomazzi CB; Kiss G; Pioner SR; Rodrigues PD Arq Bras Cir Dig; 2021; 33(3):e1549. PubMed ID: 33470379 [TBL] [Abstract][Full Text] [Related]
25. The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and nonalcoholic fatty liver disease at high risk of liver fibrosis. Alkharaiji M; Anyanwagu U; Crabtree T; Idris I Surg Obes Relat Dis; 2021 Apr; 17(4):792-798. PubMed ID: 33676874 [TBL] [Abstract][Full Text] [Related]
26. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study. Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531 [TBL] [Abstract][Full Text] [Related]
27. Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese. Ooi GJ; Burton PR; Doyle L; Wentworth JM; Bhathal PS; Sikaris K; Cowley MA; Roberts SK; Kemp W; O'Brien PE; Brown WA Obes Surg; 2017 Jan; 27(1):115-125. PubMed ID: 27220852 [TBL] [Abstract][Full Text] [Related]
28. Improvement in quality of life after bariatric surgery: sleeve versus bypass. Versteegden DPA; Van Himbeeck MJJ; Nienhuijs SW Surg Obes Relat Dis; 2018 Feb; 14(2):170-174. PubMed ID: 29150392 [TBL] [Abstract][Full Text] [Related]
29. Thirty-day outcomes of sleeve gastrectomy versus Roux-en-Y gastric bypass: first report based on Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database. Chaar ME; Lundberg P; Stoltzfus J Surg Obes Relat Dis; 2018 May; 14(5):545-551. PubMed ID: 29551470 [TBL] [Abstract][Full Text] [Related]
30. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial. Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897 [TBL] [Abstract][Full Text] [Related]
31. Bariatric Surgery in Patients with a History of Nephrolithiasis: 24-h Urine Profiles and Radiographic Changes After Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy. Uy M; Di Lena R; Hoogenes J; Alharbi B; Gmora S; Shayegan B; Matsumoto ED Obes Surg; 2021 Apr; 31(4):1673-1679. PubMed ID: 33387265 [TBL] [Abstract][Full Text] [Related]
32. Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort. Koh ZJ; Salgaonkar HP; Lee WJJ; Kim GW; Tan CH; Cheng A; Lomanto D; So JBY; Dan YY; Shabbir A Obes Surg; 2019 Mar; 29(3):862-868. PubMed ID: 30515622 [TBL] [Abstract][Full Text] [Related]
33. Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity. Perdomo CM; Gómez-Ambrosi J; Becerril S; Valentí V; Moncada R; Fernández-Sáez EM; Méndez-Giménez L; Ezquerro S; Catalán V; Silva C; Escalada J; Frühbeck G; Rodríguez A Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884755 [TBL] [Abstract][Full Text] [Related]
34. Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort. Coleman KJ; Wellman R; Fitzpatrick SL; Conroy MB; Hlavin C; Lewis KH; Coley RY; McTigue KM; Tobin JN; McBride CL; Desai JR; Clark JM; Toh S; Sturtevant JL; Horgan CE; Duke MC; Williams N; Anau J; Horberg MA; Michalsky MP; Cook AJ; Arterburn DE; Apovian CM; JAMA Surg; 2022 Oct; 157(10):897-906. PubMed ID: 36044239 [TBL] [Abstract][Full Text] [Related]
35. Guiding Patients Toward the Appropriate Surgical Treatment for Obesity: Should Presurgery Psychological Correlates Influence Choice Between Roux-en-Y Gastric Bypass and Vertical Sleeve Gastrectomy? Ames GE; Heckman MG; Diehl NN; Shepherd DM; Holgerson AA; Grothe KB; Kellogg TA; Bowers SP; Clark MM Obes Surg; 2017 Oct; 27(10):2759-2767. PubMed ID: 28815388 [TBL] [Abstract][Full Text] [Related]